We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oridis Licenses Tissue Microarray Technology

By Labmedica staff writers
Posted on 05 Dec 2006
Oridis Biomed (Graz, Austria), a biopharmaceutical company, announced that it has entered into a license agreement with the National Institutes of Health (NIH, Bethesda, MD, USA) for the worldwide commercial use of NIH's proprietary tissue microarray (TMA).

TMAs are a tool within Oridis Biomed's Tissomics platform, which permits the rapid and simultaneous study of several hundred tissue samples, using standardized high-throughput analysis by in-house pathologists.

"We are pleased to have been granted by the NIH a license for this TMA technology”, said Georg Casari, Ph.D., head of Oridis Biomed's Tissomics business. More...
"This license agreement further strengthens our Tissomics business for the life-science industry worldwide, where we offer our clients the ability to validate their research, such as biomarker and target verification programs.”

Oridis Biomed commercializes its proprietary Tissomics platform in collaboration with industrial partners, as well as its own research and development programs. The company is developing diagnostics, biomarkers (targeted treatment solutions), and therapeutics for liver diseases. Therapeutic programs include primary liver cancer (hepatocellular carcinoma, HCC) and metabolic liver diseases, such as alcoholic steatohepatitis (ASH) and non- alcoholic steatohepatitis (NASH), where incidence rates are rapidly increasing, while treatment options are limited, expensive, and often ineffective.



Related Links:
Oridis Biomed
National Institutes of Health

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.